Microbiome and cancer immunotherapy.
Curr Opin Biotechnol
; 65: 114-117, 2020 10.
Article
en En
| MEDLINE
| ID: mdl-32192986
ABSTRACT
Immunomodulation has become a promising and growing field of cancer research. Compelling results from a variety of studies provide strong evidence for the importance of commensal bacteria on oncologic outcomes and response to antitumor immunotherapies. The gut microbiome has emerged as a new prognostic biomarker and a potential therapeutic target to enhance the efficacy of immunotherapy.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Microbiota
/
Microbioma Gastrointestinal
/
Neoplasias
Límite:
Humans
Idioma:
En
Año:
2020
Tipo del documento:
Article